Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck Hid Evidence Of Vioxx Harm: Study
Pharmalot
Tuesday, July 10, 2012 - 12:11pm
tags:
Vioxx, Merck
Athersys receives orphan drug designation for MultiStem
The Fly on the Wall
Tuesday, July 10, 2012 - 12:11pm
tags:
orphan drugs, MultiStem, Athersys
Cubist Sues Hospira Over Cubicin Bacteria Medicine Patent
Bloomberg
Tuesday, July 10, 2012 - 11:47am
tags:
Cubicin, Cubist, Hospira, MRSA
U.S. Patients Get Access To More Cancer Drugs, But Pay For The Privilege
Forbes
Tuesday, July 10, 2012 - 11:34am
tags:
cancer
Exclusive: Icahn offered to settle with Forest before battle
Reuters
Tuesday, July 10, 2012 - 11:18am
tags:
Carl Icahn, Forest Labs
Onyx Pharma Must Start Delivering Profits
TheStreet.com
Tuesday, July 10, 2012 - 11:17am
tags:
ONYX Pharmaceuticals
CEO of Indian drugmaker Ranbaxy Laboratories planning expansion in US and emerging markets
Yahoo/AP
Tuesday, July 10, 2012 - 11:16am
tags:
India, emerging markets, Ranbaxy
Pfizer May Sink On New Drug Woes
Seeking Alpha
Tuesday, July 10, 2012 - 11:15am
tags:
Pfizer, Abbott Laboratories, Bristol-Myers Squibb, Shire, Watson Pharmaceuticals
Bristol-Myers starts tender offer for Amylin
Reuters
Tuesday, July 10, 2012 - 11:14am
tags:
tender offer, M&A, Amylin, Bristol-Myers Squibb
Earnings Preview: Forest Laboratories
Seeking Alpha
Tuesday, July 10, 2012 - 11:13am
tags:
earnings, Forest Labs
3 Things to Watch With Gilead Sciences
Motley Fool
Tuesday, July 10, 2012 - 11:13am
tags:
Gilead, patents, hepatitis C
Illumina: The future of DNA
Forbes
Monday, July 9, 2012 - 5:21pm
tags:
Illumina, DNA, gene sequencing
Why Sequenom's Sinking in 2012
Motley Fool
Monday, July 9, 2012 - 5:20pm
tags:
Sequenom
Alnylam Far From Primetime, But Still An Intriguing Prospect
Seeking Alpha
Monday, July 9, 2012 - 5:19pm
tags:
Alnylam, Isis, Regeneron, Amgen
FDA orders drugmakers to fund safety training for prescribers of long-acting painkillers
Yahoo/AP
Monday, July 9, 2012 - 5:10pm
tags:
FDA, opioids, painkillers
Spectrum Pharmaceuticals Q2 Earnings Estimations: Another Blowout Quarter
Seeking Alpha
Monday, July 9, 2012 - 1:02pm
tags:
earnings, Spectrum Pharmaceuticals
Dendreon, Prostate Drug Maker, Sued Over 2011 Stock Drop
Bloomberg
Monday, July 9, 2012 - 12:55pm
tags:
Provenge, Dendreon, lawsuits
Savient to cut jobs, names new CEO
Reuters
Monday, July 9, 2012 - 12:18pm
tags:
Savient, layoffs, restructuring
Questcor Stock Hits High On June Acthar Sales Figures
Investors.com
Monday, July 9, 2012 - 11:26am
tags:
Acthar, Questcor
Vivus Insiders Sell Stock Ahead of Crucial FDA Approval Decision
TheStreet.com
Monday, July 9, 2012 - 11:25am
tags:
Vivus, FDA, Qnexa

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.